Managing complexity : A model of development

During these years of accelerated transformation, INNOTHERA’s main strength was to promote a model of growth whose functioning takes into account the difficulties encountered on the markets.

Regulatory difficulties: The increasingly stringent regulations make the crucial phase of product licensing in each country longer, complex, and more and more costly, and very significantly increase production costs in a context where prices are frozen.

Added to all these difficulties is the industrial complexity resulting from the integration of the medical-textiles business area, the multiplication of galenic forms and presentations for the medicinal products, the maintenance of ISO certification, and finally permanent adaptation to increasingly stringent GMP standards.Mastering these business areas and these constraints for all of the different markets requires sustained, long-term investment in the company’s human capital. Our workforce (40% of whom are now at the production sites) and the company’s skills have developed throughout this period in order to make the change successfully.